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Abstract
Background: Hip fracture is a common injury in older people with a high rate of postoperative morbidity and
mortality. This patient group is also at high risk of acute kidney injury (AKI) and chronic kidney disease (CKD), but
little is known of the impact of kidney disease on outcome following hip fracture.
Methods: An observational cohort of consecutive patients with hip fracture in a large UK secondary care hospital.
Predictive modelling of outcomes using development and validation datasets. Inclusion: all patients admitted
with hip fracture with sufficient serum creatinine measurements to define acute kidney injury. Main outcome
measures – development of acute kidney injury during admission; mortality (in hospital, 30-365 day and to
follow-up); length of hospital stay.
Results: Data were available for 2848 / 2959 consecutive admissions from 2007-2011; 776 (27.2%) male. Acute
kidney injury occurs in 24%; development of acute kidney injury is independently associated with male sex (OR 1.48
(1.21 to 1.80), premorbid chronic kidney disease stage 3B or worse (OR 1.52 (1.19 to 1.93)), age (OR 3.4 (2.29 to 5.2)
for >85 years) and greater than one major co-morbidities (OR 1.61 (1.34 to 1.93)). Acute kidney injury of any stage is
associated with an increased hazard of death, and increased length of stay (Acute kidney injury: 19.1 (IQR 13 to 31)
days; no acute kidney injury 15 (11 to 23) days). A simplified predictive model containing Age, CKD stage (3B-5),
two or more comorbidities, and male sex had an area under the ROC curve of 0.63 (0.60 to 0.67).
Conclusions: Acute kidney injury following hip fracture is common and associated with worse outcome and
greater hospital length of stay. With the number of people experiencing hip fracture predicted to rise, recognition
of risk factors and optimal perioperative management of acute kidney injury will become even more important.
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Background
Hip fractures are a common injury in the elderly in the
United Kingdom [1] and worldwide [2]. These patients
are at high risk for protracted length of stay, post-
operative mortality and morbidity and reduction in qual-
ity of life [3]. Any patients who develop post-operative
acute kidney injury (AKI) are also likely to have an in-
creased length of stay and a greater likelihood of in
hospital mortality and morbidity [4–9].
Little has been published on patients who have both
problems, although The Scottish Intercollegiate Group
hip fracture guidelines identified pre- and post-operative
hydration and pre-admission renal dysfunction as areas
requiring further attention and research [1]. Previous
studies on hip fracture [10] and AKI [11] have provided
patchy information based on admission serum creatinine
(SCr) values or small populations. Current concepts in
renal injury highlight increasing age, pre-existing chronic
kidney disease, male gender, diabetes mellitus, heart fail-
ure and surgery as major risk factors for AKI [12–14].
However, in the hip fracture population, these may be
relatively non-sensitive and non-specific risk factors
since two thirds of these patients are aged over 80 and
co-morbidity, including chronic kidney disease (CKD), is
common at admission. Relatively small changes in SCr
can predict or indeed define AKI. These changes may be
missed or discounted in this population, particularly in
the early stages of AKI. Although many underlying risk
factors for AKI may not be modifiable in this cohort, an
understanding of the risks of developing AKI, and the
consequences for the patient, may be of use for the
multidisciplinary team caring for these patients.
The aim of this study was to describe the renal mor-
bidity of the hip fracture population and its association
with short and long-term mortality and to identify key
risk factors for AKI within this population. We also
wished to use these data to develop and validate a risk
prediction model for development of AKI following
hip fracture.
Methods
Nottingham University Hospitals NHS Trust has two
substantial clinical databases developed by the Depart-
ments of Trauma and Orthopaedic Surgery and Renal
and Transplantation. The Nottingham Hip Fracture
database has been described previously [15, 16] and con-
tains prospectively collected, quality controlled dataset
based on the Standardised Audit of Hip Fractures in
Europe (SAHFE) process [17].
The NUH renal AKI database is the largest single
centre AKI database in the United Kingdom. It was
developed in parallel with the Nottingham AKI e-alert,
an automated real-time electronic alerting system that
uses algorithms based on internationally recognised SCr-
based definitions of AKI [18]. The AKI database includes
all adult patients admitted overnight to Nottingham
University Hospitals.
Data were extracted from the Hip fracture and AKI
databases in accordance with Caldicott principles. We
identified completed hospital episodes between 01/04/
2007 and 31/03/2011 where a patient was admitted
following hip fracture and where sufficient serial serum
creatinine measurements were available to allow identi-
fication and staging of AKI using the 2012 Kidney
Diseases Improving Global Outcomes (KDIGO) classifi-
cation [19]. The AKI database automatically excludes
patients known to be receiving regular dialysis for end-
stage renal disease and patients who die before an over-
night admission.
The Nottingham Hip Fracture Score (NHFS) was
calculated for all patients. The NHFS is essentially a
weighted seven factor frailty score specific to hip frac-
ture: Age; Cognitive function on admission (Abbreviated
Mental Test Score [20] <7); not living at home; sex
(male); haemoglobin < 100 g L-1; previous malignancy;
>1 comorbidity (stroke/transient ischaemic attack; car-
diovascular disease; diabetes; previously diagnosed
renal disease. It has previously been shown to predict
30-day post hip fracture mortality in the UK [21, 22]
and internationally [23].
Basic patient characteristics recorded included: age;
gender; ethnicity; and pre-admission renal function.
Definitions and calculation of kidney dysfunction
Acute Kidney Injury (AKI)
For AKI staging, two serum creatinine (SCr) values
are required. The renal database algorithm uses pre-
admission baseline SCr (defined as the average Scr from
all values measured 7-365 days pre hospitalisation), and
compares this with first in-hospital measured Scr (AKI
stage at admission). If a pre admission baseline is not
available then an estimated Scr (eSCr) is calculated as-
suming a theoretical estimated glomerular filtration rate
(eGFR) of 75 ml/min/1.73 m2 and using backward calcu-
lation of the Modification of Diet and Renal Disease
(MDRD) [24] equation, as recommended by KDIGO.
Staging of AKI is revised throughout the admission after
each new SCr result and the overall worst AKI stage is
recorded as the final AKI stage for the hospital episode.
Ideally urine output criteria for AKI definition would be
used in addition to SCr criteria but these data are not
routinely recorded electronically and urine output
measurement is not reliable in non-catheterised or in-
continent patients (Table 1).
Chronic kidney disease (CKD)
CKD stage was calculated in patients with an actual
baseline and a post discharge SCr. Pre-admission CKD
Porter et al. BMC Nephrology  (2017) 18:20 Page 2 of 11
stage was calculated using mean pre admission SCr, age,
gender and ethnicity. Post-discharge CKD was calculated
using mean post-discharge SCr (measured between 90 and
365 days following discharge), age, gender and ethnicity.
Post-operative outcomes
Data were retrieved for: length of acute hospital stay;
time to death (in hospital and post-discharge); postop-
erative admission to critical care; renal recovery (per-
centage change comparing 90-365 day post discharge
SCr and pre-admission known baseline) and dialysis de-
pendence (defined as attending dialysis clinic 90-365
days post discharge).
A minimum 90 day time frame for renal recovery is
used to assess renal outcome post discharge, in accord-
ance with the Kidney Disease Outcomes Quality Initia-
tive guidelines which defines CKD as a persistent decline
in kidney function lasting > 90 days [25], otherwise pa-
tients are defined as recovered renal function.
Statistical methods
Data were analysed using R statistical package [26]. Con-
tinuous variables are presented as mean (95% confidence
interval) or median [inter-quartile range] as appropriate.
Categorical variables are described as proportions of the
cohort. Student’s t-test was used to compare parametric
data and the Mann-Whitney U-test was used to compare
non-parametric data. Group comparisons were by either
two-by-two contingency table with Chi-squared analysis,
Kruskal-Wallis or ANOVA for multiple groups. Two-
tailed P-values were calculated and a value of less than
0.05 was considered significant.
Modelling and prediction
Multivariate analysis of factors predictive of develop-
ment of AKI was performed.
Logistic regression was conducted using development
of AKI as the outcome and using all predictors with p <
0.2 on univariate analysis. Backwards elimination was
used to optimise Akaike’s Information Criterion. Sensi-
tivity analyses of this modelling were conducted: using
age as a continuous rather than a categorical variable;
and imputing CKD stage 2 for those patients without a
measured pre-admission SCr.
Hazard ratios (HR) for mortality, with associated
95% confidence intervals (CI) were derived from Cox
proportional hazard models stratified by AKI severity
(using no AKI as the reference) or pre-admission eGFR
(average for 7-365 days pre admission) group (using
eGFR >60 ml/min/1.73 m2 as the reference) including
age and sex as co-variates. Analyses were repeated using
imputed CKD stage 2 (eGFR >60 ml/min/1.73 m2) for
all those patients without a baseline SCr.
Predictive modelling
The full dataset was split at random [27] into training
and testing subsets (ratio 0.66:0.34) using development
of AKI as a sampling variable. Predictive risk scoring
models were created using logistic regression modelling
of the training dataset [28] using the predictors identi-
fied in the association modelling. Models were created
using only patients with known pre-admission SCr and
using imputed CKD stage 2 (eGFR >60 ml/min/1.73 m2)
for all those patients without a baseline SCr. Model
performance was assessed using Receiver Operating
Characteristic (ROC) curves (ROC) (discrimination)
and Hosmer-Lemeshow tests (calibration). Confidence
intervals for area under the ROC curve (AUROC) were
calculated using DeLong’s method [29] and confidence
intervals for test performance measures were calculated
using Wilson’s method [30] and Koopman’s method
[31] (Likelihood ratios). The modelling is reported in
accordance with the TRIPOD statement [32].
A simplified score was created based on the predictive
modelling and assessed for discrimination and calibra-
tion on the testing subset as above.
Results
We identified 2959 completed hospital episodes between
01/04/2007 and 31/03/2011, where a patient was admit-
ted for hip fracture and sufficient serial Scr measure-
ments were collected to allow presence or absence of
AKI to be defined. The revised NHFS (11) was available
in 96.2% (2848/2959). A valid SCr from the time period
7-365 days before admission was available for 2044/2848
patients (71.8%). Median (IQR [range]) follow-up was
691 (215 - 1119 [1 -2151]) days.
The distribution of NHFS was very similar to those
previously reported [15, 16, 20, 33] with median (IQR)
[range] of 4 (3-6) [0-10]. Of the 2848 individual hospital
episodes, 683 patients (24%) developed AKI. These were
divided into stage 1 (483/683 patients 70.7%), stage 2
(136/683 19.8%), and stage 3 (64/683 9.4%). Four pa-
tients required renal replacement therapy for AKI (1
from stage 2 and 3 from stage 3).
Tables 2 and 3 details patient characteristics and out-
comes. Patients who developed AKI were older than
those who did not (85 [78.6 to 89.8] vs 82.6 [75.2 to 87.9]
Table 1 KDIGO definition and staging of Acute Kidney Injury
Stage 1 Increase in Scr of 1.5 to 1.99 times baseline
OR≥ 0.3 mg/dl (≥26.5 μmol/l) increase.
Stage 2 Increase of between 2 and 2.99 times baseline
Stage 3 Increase of 3 times or more baseline OR increase
in Scr to ≥ 4.0 mg/dl (≥353.6 μmol/l) after previous
stage 1 OR initiation of renal replacement therapy
(a retrospective staging).
KDIGO Kidney Disease | Improving Global Outcomes
SCr Serum creatinine
Porter et al. BMC Nephrology  (2017) 18:20 Page 3 of 11
Table 2 Characteristics and outcomes of included participants according to Acute Kidney Injury stage
Characteristics
Median [IQR]
Number (proportion %)
No AKI
2165
All AKI
683
Stage 1
483
Stage 2
135
Stage 3
64
P value
No AKI vs. All AKI
Age, years 82.6
[75.2 to 87.9]
85.0
[78.6 to 89.8]
85.5
[78.6 to 89.9]
84.3
[78.5 to 89.6]
83.9
[77.4 to 88.9]
<0.001
Male 562
(26.0)
214
(31.3)
154
(31.9)
38
(27.9)
22
(34.4)
<0.001
Number (%) with known baseline SCr 1587
(73.3)
457
(66.9)
342
(70.8)
75
(55.0)
40
(62.5)
0.001
Baseline eGFR mls/min/1.73 m2 64
[50 to 77]
57
[43 to 74]
57
[42 to 72]
63
[48 to 72]
58
[37 to 81]
<0.001
CKD stage > =3 658/1587
(41.5)
243/457
(53.1)
186/342
(54.3)
36/75
(48)
21/40
(52.5)
<0.001
Diabetes 266
(12.3)
127
(18.6)
84
(17.4)
28
(20.7)
15
(23.4)
<0.0001
Previous Stroke or TIA 271
(11.9)
104
(15.2)
72
(14.9)
19
(14.1)
13
(20.3)
0.069
Cardiovascular disease 1157
(52.8)
438
(64.1)
301
(62.3)
92
(68.1)
45
(70.3)
<0.0001
Greater than one defined co-morbidity 658
(30.3)
301
(44.1)
205
(42.4)
61
(45.2)
35
(54.7)
<0.0001
Admission AMTS <7 743
(34.3)
244
(35.7)
171
(35.4)
49
(36.3)
24
(37.5)
0.5
Admission haemoglobin < 100 g L-1 154
(7.1)
61
(8.9)
49
(10.1)
8
(5.8)
4
(6.3)
0.13
Not admitted from home 441
(20.3)
90
(18.6)
32
(23.5)
9
(14)
131
(19.2)
0.51
Nottingham Hip Fracture Score 4
[3–5]
5
[4–6]
5
[4–6]
5
[4–6]
5
[4–6]
<0.0001
Nottingham Hip Fracture Score > = 4 1544
(71.3)
583
(85.4)
414
(83.1)
113
(83.1)
56
(87.5)
<0.0001
Nottingham Hip Fracture Score > = 5 1044
(48.2)
417
(61.1)
302
(62.5)
75
(66.4)
40
(62.5)
<0.001
AKI Acute Kidney Injury, AMTS Abbreviated mental test score
eGFR estimated glomerular filtration rate, SCr Serum creatinine
CKD Chronic kidney disease
Table 3 Outcomes of included participants according to Acute Kidney Injury stage
Characteristics
Median [IQR]
Number (proportion %)
No AKI
2165
All AKI
683
Stage 1
483
Stage 2
135
Stage 3
64
P value
No AKI vs. All AKI
Length of Stay, days 15
[11–23]
19.1
[13–31]
19
[13–31]
20
[12.3 to 32.5]
20
[12–32]
<0.001
Part stay in critical care 40
(1.8)
41
(6.0)
16
(3.3)
11
(8.1)
14
(21.9)
<0.001
Proportion admitted multiple times, all 4 yrs. 1378
(63.6)
401
(58.7)
301
(62.3)
71
(52.2)
29
(45.3)
0.020
In patient deaths 134
(6.2)
169
(24.7)
100
(20.7)
39
(28.7)
30
(46.9)
<0.001
30-day mortality 139
(6.4)
131
(19.2)
79
(16.4)
27
(19.9)
25
(39.1)
<0.001
1 year mortality 534
(24.7)
305
(44.7)
203
(42.0)
61
(44.9)
41
(64.1)
<0.001
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years, p < 0.0001). This was true for men (83.8 [74.9 to
88.5] vs 78.3 [66.5 to 85.7], p < 0.0001) and women (86.0
[80.1 to 90.1] vs 83.8 [77.1 to 88.6] years, p < 0.0001).
Patients with AKI were more likely to be male than
those who were not (31.3% vs. 26%, p < 0.001). Length
of stay was 15 [11 to 23] days for the no AKI group and
19 [13 to 31] days in those with AKI (p < 0.0001). Use of a
critical care bed post-operatively increased with increasing
stage of AKI.
Table 2 details the univariate analysis of potential risk
factors for development of AKI. Multivariate analysis
with optimisation of AIC showed age, pre-existing CKD,
sex and two or more co-morbidities to be independently
predictive of development of AKI (Table 4, Fig. 1).
Pre admission chronic kidney disease
The risk of developing AKI, and its severity, were associ-
ated with pre-admission SCr and eGFR. For the 2044
patients with a documented pre-admission SCr, Table 4
shows the inverse relationship between pre-admission
eGFR, incidence and severity of AKI and 30-day mortal-
ity. In the no AKI group 26.7% (578/2165) did not have
a pre-admission SCr available, whilst in the AKI group
(all stages) it was 33% (226/683). For each stage of AKI
the proportions without a known pre- admission SCr
were: stage 1 29.2% (141/483), stage 2 44.4% (60/135)
and stage 3 37.5% (24/64).
Pre-admission baseline eGFR (n = 1946) was inversely
associated with in-hospital mortality within the whole
cohort: eGFR <30 ml/min/1.73 m2 – 32.9% in-hospital
mortality (25/76); eGFR 30-60 ml/min/1.73 m2 – 12.4%
(98/727) and eGFR >60 ml/min/1.73 m2 - 10.4% (119/1143).
Survival following hip fracture
Mortality as an inpatient, 30-days and one year was in-
creased for those patients who developed AKI and those
with pre-existing chronic kidney disease (Tables 3 and 5;
Figs. 2 and 3).
Multivariate analysis identified age (continuous and
categorised), male sex, pre-existing CKD > =3B and
AMTS <7 as independent risk factors for 30-day mor-
tality (Table 6). The results were trivially different whether
imputed or unknown CKD stage was used (Fig. 4).
Cox proportional hazards modelling including all the
elements of the Nottingham Hip Fracture Score, CKD
stage and AKI grade identified age (65-85 years 2.4
(1.8-3.3); >85 years 4.0 (3.0 – 5.4)), male sex (, all AKI
grades, AMTS <7, residential status (all p < 0.0001),
haemoglobin < 100 g L-1, (p = 0.0003), CKD stages >
=3B (p = 0.003) and >1 comorbidity (p = 0.0003) as
independent risk factors (Table 7).
Survivors and renal outcome
Of the 2545 survivors to hospital discharge, 48.2%
(1227) had both a pre and post admission eGFR avail-
able. Incidence of any stage of AKI was 17.6% (216/
1227) in this group.
Pre-admission and post-discharge eGFR were corre-
lated for both no AKI and AKI groups (r2 0.79 and r2
0.82, P < 0.001 respectively). There was a statistically but
not clinically significant improvement in renal function
following discharge in the no AKI group (n = 1011) (63
[50 to 77] ml/min/1.73 m2 vs. 67 (53 to 83) ml/min/
1.73 m2 (p = 0.0002). There was no change in the AKI
group (n = 216) (59 [47 to 77] l/min/1.73 m2 vs 60 [48 to
77] ml/min/1.73 m2 (p = 0.48).
Risk prediction models
Two risk prediction models were developed using the
training set and the previously identified predictors. The
Table 4 Multivariate risk factors for development of Acute
kidney injury during admission
Coefficients OR (95% CI) p
Intercept -2.476 <0.0001
Male sex 0.390 1.48 (1.21 to 1.80) 0.0004
CKD stage 3B-5 0.417 1.52 (1.19 to 1.93) 0.0008
Age 65 – 85 0.896 2.45 (1.66 to 3.74) <0.0001
Age > 85 1.223 3.40 (2.29 to 5.20) <0.0001
Two or more comorbidities 0.475 1.61 (1.34 to 1.93) <0.0001
Patients without known Scr were imputed to CKD stage 2. The results for
all predictors are almost identical if age is used as a continuous variable
(OR 1.033 (1.024 to 1.043), p < 0.0001)
AKI Acute Kidney Injury
CKD Chronic kidney disease
SCr Serum creatinine
Fig. 1 Multivariate odds ratios of developing AKI following
admission with hip fracture
Porter et al. BMC Nephrology  (2017) 18:20 Page 5 of 11
patient characteristics and outcomes of the two groups
were similar (Tables 8 and 9).
Model 1: Age (<65, 65-85, >85), CKD stage (3B-5),
two or more comorbidities, sex (male)
Model 2: Age (continuous), CKD stage (3B-5), two or
more comorbidities, sex (male)
A third model was tested using a simplified scoring
system based on Model 1 (Table 10). The predicted risk
from the new score is calculated as:
Predicted risk ¼ 1= 1 þ e 2:264 – NHRISK=4½ ð Þ
 
Where NH-RISK is the sum of the individual scores
Areas under the ROC curves were 0.63 (0.59 to 0.67),
0.65 (0.61 to 0.69) and 0.63 (0.60 to 0.67) respectively.
Calibration was adequate for all three models (p = 0.464,
0.438 and 0.847) (Table 11; Figs. 5 and 6).
Discussion
Our main findings are: first, AKI occurs in 1 in 4 hip
fracture patients; second, mortality risk and acute length
of stay increase with increasing severity of AKI; third,
male sex, older age, pre-admission CKD and having
more than one comorbidity are independent risk factors
for AKI; and lastly, mortality risk post hip fracture is
increased if pre-injury eGFR is <30 ml/min/1.73 m2.
Table 5 Acute kidney injury and mortality according to pre-admission estimated glomerular filtration rate
Pre admission
creatinine
eGFR grouping
Number AKI stage during admission
Number (% of CKD group)
Mortality Number (%)
No AKI Stage 1 Stage 2 Stage 3 All AKI 30 Day One year
<15 ml/min/1.73 m2 10 1
(10)
3
(30)
0
(0)
6
(60)
9
(90)
5
(50)
9
(90)
15-29 ml/min/1.73 m2 66 36
(54.5)
25
(37.9)
4
(6.1)
1
(1.5)
30
(45.4)
19
(28.8)
37
(56.1)
30-44 ml/min/1.73 m2 292 202
(69.2)
72
(21.1)
11
(14.7)
7
(17.5)
90
(19.7)
46
(15.8)
118
(40.4)
45-59 ml/min/1.73 m2 533 419
(26.4)
86
(25.1)
21
(28.0)
7
(17.5)
114
(25.0)
50
(9.4)
157
(29.4)
>60 ml/min/1.73 m2 1143 929
(58.5)
156
(45.6)
39
(52.0)
19
(47.5)
214
(46.8)
97
(8.5)
350
(30.1)
Total 2044 1587
(100)
342
(100)
75
(100)
40
(100)
457
(100)
217
(10.6)
671
(32.8)
AKI Acute Kidney Injury
eGFR estimated glomerular filtration rate
CKD Chronic kidney disease
Fig. 2 Kaplan Meier plot of cumulative probability of mortality day
adjusted for age and gender and stratified for AKI severity
Fig. 3 Kaplan Meier plot of cumulative probability of mortality day
adjusted for age and gender and stratified for CKD severity
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The incidence of AKI in this large hip fracture popula-
tion was 24%. This is greater than has previously been
reported and is around twice as common as in the gen-
eral surgical population [34]. White and colleagues [10]
reported an incidence of 36.1% of patients whose esti-
mated GFR on admission was < 60 ml/min/1.73 m2, but
were unable to comment on whether this was acute,
chronic or both. Previous studies of AKI following hip
fracture have used considerably smaller sample sizes
(<200) and have reported AKI incidence at around 16%
[11] using either Acute Kidney Injury Network (AKIN)
[25] or RIFLE [35] classifications of AKI. Until the publi-
cation of the KDIGO guidelines in 2012 this has been a
major source of inconsistency in the classification and
reporting of AKI incidence. This study is the first to use
this validated classification and uses a large population
suggesting that incidence has been under-estimated pre-
viously. Increasing age and male gender have previously
Table 6 Risk factors for thirty-day mortality identified using
multivariate logistic regression
Coefficient OR (95% CI) p
Intercept -3.786 <0.0001
Male sex 1.050 2.86 (2.16 to 3.77) <0.0001
CKD stage > =3B 0.717 2.05 (1.47 to 2.84) <0.0001
Age 65 - 85 0.981 2.67 (1.29 to 6.48) 0.0159
Age >85 1.801 6.05 (2.94 to 14.66) <0.0001
AMTS <7 0.505 1.66 (1.26 to 2.17) 0.0002
AKI during admission 1.008 2.74 (2.09 to 3.59) <0.0001
Two or more comorbidities 0.383 1.47 (1.11 to 1.93) 0.0067
Patients with no known baseline eGFR were assigned to CKD Stage 2. The
results for all predictors are almost identical if age is used as a continuous
variable (OR 1.069 (1.051 to 1.087); p <0.0001)
AKI Acute Kidney Injury
eGFR estimated glomerular filtration rate
CKD Chronic kidney disease
AMTS Abbreviated mental test score
Fig. 4 Multivariate odds ratios of 30-day mortality following admis-
sion with hip fracture
Table 7 Hazard ratios for mortality using Cox proportional
hazards modelling
Hazard Ratio (95% CI) p
Age 65 - 85 2.4 (1.8 to 3.3) <0.0001
Age >85 4.0 (3.0 to 5.4) <0.0001
Male sex 1.8 (1.6 to 2.1) <0.0001
AMTS <7 1.6 (1.4 to 1.8) <0.0001
Not admitted from home 1.6 (1.4 to 1.8) <0.0001
Admission haemoglobin < 100 g L-1 1.4 (1.2 to 1.8) 0.0003
Two or more comorbidities 1.5 (1.3 to 16) <0.0001
Any AKI 1.6 (1.4 to 1.8) <0.0001
CKD stage > =3B 2.05 (1.47 to 2.84) <0.0001
Table 8 Comparison of training and testing datasets – patient
characteristics
Characteristics
Median [IQR]
Number (proportion %)
Training set
(N = 1880)
Testing set
(N = 968)
Age, years 82.9
[75.5 to 88.3]
83.7
[76.8 to 88.6]
Male 534
(28.4)
242
(25.0)
Number (%) with known baseline SCr 1352
(71.9)
692
(71.5)
Baseline eGFR mls/min/1.73 m2 63
[50 to 78]
61
[48 to 75]
CKD stage > =3 583
(43.1)
318
(46.0)
Diabetes 261
(13.9)
132
(13.6)
Previous Stroke or TIA 234
(12.4)
131
(13.5)
Cardiovascular disease 1011
(53.8)
540
(55.8)
Greater than one defined co-morbidity 629
(33.5)
330
(34.1)
Admission AMTS <7 619
(32.9)
368
(38.0)
Admission haemoglobin < 100 g L-1 538
(28.6)
314
(32.4)
Not admitted from home 363
(19.3)
209
(21.6)
Nottingham Hip Fracture Score 4
[3–6]
5
[4–6]
Nottingham Hip Fracture Score > = 4 1389
(73.9)
738
(76.2)
Nottingham Hip Fracture Score > = 5 908
(48.3)
513
(53.0)
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been reported as being associated with poorer outcomes
after hip fracture [30, 36]. A large meta-analysis incorp-
orating 94 studies reported advancing age and male gen-
der to be the two strongest predictors of mortality in hip
fracture surgery patients [37]. We add to this knowledge
with another large study. Both chronic kidney disease
(CKD) and AKI are associated with greater and earlier
mortality [38–41]. Patients with pre-admission eGFR
<30 ml/min/1.73 m2 had a relative risk of developing
AKI of 2.4 compared with those with eGFR >30 ml/min/
1.73 m2, supporting data that suggest pre-existing CKD
increases risk of AKI [34, 42, 43]. AKI was associated
with an increase in mortality. Of note, stage 1 and 2 AKI
appear to carry the same intermediate increase in risk.
This would support the assertion that ‘mild’ derange-
ment of renal function, which is commonly seen (around
1 in 5) in this elderly population, is not benign. All
mortality rates (in-hospital, 30 day, 90 day and 1 year)
increased with increasing severity of AKI and with lower
pre-admission renal function, demonstrating the import-
ance of identifying both AKI and CKD in the elderly.
This is a single centre study so our data may not be
replicated elsewhere, and the inherent weaknesses of
logistic regression modelling have been discussed by
others [44]. However, outcomes following hip fracture
in Nottingham are similar to elsewhere [16, 45] and
the demographics of our hip fracture population are
similar to the rest of the UK. The rates of CKD and
AKI are similar to previous studies, bearing in mind
the differences in methodology. The strength of our
Table 9 Comparison of training and testing datasets – patient
characteristics
Characteristics
Median [IQR]
Number (proportion %)
Training set
(N = 1880)
Testing set
(N = 968)
Length of Stay, days 16
[12–25]
15
[11–24]
Part stay in critical care 54 (2.9) 26 (2.7)
Proportion admitted multiple times, all 4 yrs. 1161 (61.8) 618 (63.8)
In patient deaths 192 (10.2) 111 (11.5)
30-day mortality 164 (8.7) 106 (11.0)
1 year mortality 533 (28.4) 306 (31.6)
AKI 0 1429 (76.0) 736 (76.0)
AKI 1 320 (17.0) 163 (16.8)
AKI 2 85 (4.5) 51 (5.3)
AKI 3 46 (2.4) 18 (1.9)
Table 10 Prediction models characteristics
Model
1
Model
2
Nottingham Hip Fracture – Risk
Score for Kidney Injury (NH-RISK)
Coefficients
Intercept -2.264 -3.78 -2.264
Male sex 0.358 0.370 1
CKD stage 3B-5 0.266 0.216 1
Age (year) - 0.028
Age 65 – 85 0.705 - 3
Age > 85 1.023 - 4
Two or more
comorbidities
0.518 0.521 2
CKD Chronic kidney disease
Table 11 Calibration of the Nottingham Hip Fracture – Risk
Score for Kidney Injury (NH-RISK)
NH-RISK score Predicted risk Observed rate of AKI
(number/group size)
Full set Training set Test set
0 0.09 0.046
(5/109)
0.067
(5/75)
0
(0/34)
1 0.12 0.107
(14/131)
0.125
(12/96)
0.057
(2/35)
2 0.15 0.094
(3/32)
0.15
(3/20)
0
(0/12)
3 0.18 0.172
(102/592)
0.171
(67/391)
0.174
(35/201)
4 0.22 0.244
(206/843)
0.247
(137/554)
0.239
(69/289)
5 0.27 0.268
(134/500)
0.264
(87/329)
0.275
(47/171)
6 0.32 0.291
(125/430)
0.286
(80/280)
0.3
(45/150)
7 0.37 0.425
(76/179)
0.427
(47/110)
0.42
(29/69)
8 0.43 0.563
(18/32)
0.52
(13/25)
0.714
(5/7)
Fig. 5 Calibration plot for model 1. Data for the full dataset are
shown in grey, for the training set in green and the testing set
in blue. The area of the points is proportional to the number of
cases in each group. The line represents the line of equality,
where observed and predicted outcomes are equal
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study includes the use of two large prospectively col-
lected clinical databases with almost complete data
capture for the four-year period. We were able to esti-
mate pre-injury renal function in 72% of participants,
which allows us to diagnose AKI on admission blood
tests. We were also able to determine post-discharge
renal function. The use of calculated pre-admission
SCr, assuming normal GFR where no documented
result is available, may result in over-estimation of the
incidence and stage of AKI. Nevertheless, the data pre-
sented here demonstrate clinically relevant outcomes:
the survival curves for Stage 1 and stage 2 AKI are
essentially identical, and worse than those with no
AKI. We have not been able to identify a highly dis-
criminating combination of predictor variables – the
AUROC was relatively poor at around 0.63. However,
calibration is reasonable, suggesting that either the full
models, or the simplified 9-point NH-RISK may be
useful tools for classifying risk of AKI on admission.
Accurate assessment of risk is widely perceived to be a
driver to improved management, though direct evidence
of changes in clinical care and outcomes is lacking. We
intend to trial the use of the simplified scoring system
as part of our hip fracture admission criteria, in the
first instance simply to flag those patients identified as
highest risk of AKI who may benefit from specific clin-
ical interventions.
CKD is both a risk factor for fracture [38] and associ-
ated with poorer outcome. It is tempting to be nihilistic
and ascribe CKD as a fixed predictor of poor outcome.
However, AKI is potentially preventable in some
patients, so should be viewed as a possible target for
intervention. Simple interventions such as avoidance of
nephrotoxic drugs and correction of hypotension and
hypovolaemia are important, yet easily overlooked.
NSAIDs are usually avoidable, at least during the
period of risk for AKI. Similarly, there are often alter-
natives to nephrotoxic antibiotics such as gentamicin
but, if considered the antimicrobial of choice, nephro-
toxicity can be reduced with meticulous monitoring of
blood levels. Angiotensin converting enzyme (ACE)
inhibitors and angiotensin receptor blockers are
commonly prescribed in the elderly and are not nephro-
toxins per se. There is currently no clear evidence on
when to discontinue these drug classes peri-operatively
with respect to reducing risk of AKI. Current consensus
suggests temporary discontinuation where AKI [14] or
hypotension has developed. The risk of hypovolaemia
may be reduced by limitation of starvation times and
with intravenous fluid administration before and during
surgery. Intraoperative stroke volume guided fluid stud-
ies are currently underpowered to demonstrate statisti-
cally significant changes in development of AKI [46, 47]
and echocardiography studies [48] suggest that around
25% of patients are still hypovolaemic immediately
prior to theatre. Patients arriving in theatre with
urinary evidence of ‘dehydration’ [49] also have a worse
outcome. Hypotension, relative or absolute, is very
common intra-operatively, both with spinal and general
anaesthesia [50].
Acute kidney injury is a costly disease with National
Health Service (NHS) costs estimated to be between
£434 million and £620 million per year [14]. The English
hip fracture population is predicted to increase in size
from around 70000 per year currently to around 90-
100000 by 2033 [51]. The medical complexity of patients
with hip fracture is also increasing in particular with
increasing numbers of patients with cardiovascular and
renal disease on admission [52]. The increased require-
ments for a critical care bed and longer hospital stay
when AKI occurs add to this burden. Taken together this
would suggest that hip fracture-related AKI is likely to
have a significant and increasing financial burden in the
near future.
Conclusions
CKD and AKI are common findings in elderly hip fracture
patients. Both are independently associated with poor
outcome – mortality, critical care use and length of acute
hospital stay. They are probably markers of chronic and
acute comorbidity rather than the direct cause of death
themselves. When available, pre-injury SCr should be
obtained to facilitate early detection of AKI. The optimal
approach to preventing AKI in this population is not yet
known, but close monitoring of fluid balance, avoidance
of nephrotoxic drugs, appropriate adjustment of renally
Fig. 6 Calibration plot for the Nottingham Hip Fracture – Risk Score
for Kidney Injury (NH-RISK). Data for the full dataset are shown in
grey, for the training set in green and the testing set in blue. The
area of the points is proportional to the number of cases in each
group. The line represents the line of equality, where observed and
predicted outcomes are equal
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excreted drugs and prompt treatment of sepsis would
seem sensible in all peri-operative patients.
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